Read More Pharma Industry News Race Oncology doses first patient in phase 1b/2 AML trial of FluCloZan Race Oncology has dosed the first patient in the phase 1b/2 trial of its Zantrene (bisantrene dihydrochloride) in… bySrinathAugust 9, 2021
